Skip to main content
DCWeedHub

You must be 21+

DC cannabis information is for adults only.
Please confirm your age to continue.

By entering you agree to our Terms and Privacy Policy. Remembered for 30 days.

DC's Cannabis Hub · ABCA Licensed Only
Market DataAdvanced Analytics

DC Cannabis Market Intelligence

Deep analysis of 51 months of official ABCA data — revenue trends, patient growth, product mix, seasonality, and 10 automated market insights.

2025 Annual Revenue
$929K
+79% vs 2024
Latest Month
$93K
+57% YoY
Registered Patients
as of latest report
Cumulative Self-Certs
170,628
since program launch

Market Intelligence Insights

10 data-driven insights automatically extracted from 51 months of real ABCA data

Growth Signal+79%

Market Nearly Doubled in 12 Months

Total market revenue grew from $0.5M in 2024 to $0.9M in 2025 — a 79% annual growth rate. This makes DC one of the fastest-growing medical cannabis markets in the country.

Growth Signal+802%

Self-Cert Program: 9× Growth in Monthly Registrations

Monthly new self-certifications surged from 1,542 in Jan 2024 to a peak of 13,904 in Apr 2025 — a 802% increase. The cumulative pool crossed 100,000 patients in early 2025 and reached 170,628 by year-end.

Market Trend+190%

Manufacturing Revenue: The Fastest-Growing Segment

Licensed manufacturer sales grew 190% YoY — from $0.1M in 2024 to $0.2M in 2025. This reflects the maturation of DC's supply chain as more manufacturers entered the market post-2024 regulatory expansion.

Record

All-Time Record: $0.17M in Dec 2023

Dec 2023 set the all-time monthly revenue record at $0.17M — driven by spring tourism and early market expansion.

Market Trend

Seasonality: Dec Peaks, Feb Dips

Across all years, Dec averages the highest monthly revenue ($0.09M) while Feb is consistently the weakest month ($0.05M avg). Dispensaries should plan promotions and inventory accordingly.

Watch Out-32%

Patient Utilization Rate: 31% of Registered Patients Shop Monthly

In Feb 2026, 32,740 of 104,433 registered patients made a purchase — a 31% utilization rate. This is down from 63% in Jan 2022, indicating a growing pool of registered-but-inactive patients.

Watch Out-67%

Revenue Per Patient Visit: $2 (-67% vs 2022)

Average dispensary revenue per patient served was $2 in Feb 2026, compared to $6 in Jan 2022. Declining basket sizes may reflect increased price competition or a shift toward lower-cost products.

Market Trend

Maryland + Virginia = 80% of All Out-of-State Patients

MD and VA together account for 80% of all reciprocity patient visits. Maryland leads with 33,913 cumulative visits, followed by Virginia at 61,668. Florida, Pennsylvania, and New Jersey round out the top 5, reflecting DC's tourism draw from the Eastern Seaboard.

Opportunity+242%

Vape Cartridge: Fastest-Growing Product Category (+242% YoY)

Vape Cartridge sales grew 242% from 2024 to 2025 — from $3057K to $10451K annually. Dispensaries stocking this category are well-positioned to capture growing consumer demand.

Growth Signal

Longest Consecutive Growth Streak: 6 Months

The market sustained 6 consecutive months of revenue growth — a sign of structural demand expansion rather than seasonal spikes. This streak was driven by the self-cert program's rapid patient acquisition phase in early-to-mid 2025.

Executive Scorecard

Key performance indicators across the full dataset

2024 Total Revenue
$518K
2025 Total Revenue
$929K
+79.3%vs 2024
2026 YTD Revenue
$266K
3 months
All-Time Record Month
$172K
Dec 2023
Peak Monthly Self-Certs
13,904
Apr 2025
Patient Utilization Rate
31%
shop monthly
Revenue Per Patient Visit
$2
avg dispensary basket
Consecutive Growth Streak
6 months
longest MoM run

Full Revenue Timeline

All months from 2024–2026 with dispensary, cultivation, and manufacturer breakdown

Monthly Total Revenue — Stacked by Segment ($M)

Jan '22Apr '22Jul '22Oct '22Jan '23Apr '23Jul '23Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '26$0.0M$0.0M$0.1M$0.1M$0.1M
  • Dispensary
  • Cultivation
  • Manufacturer

Month-over-Month Revenue Change (%)

Feb '22Jun '22Oct '22Feb '23Jun '23Oct '23Feb '24Jun '24Oct '24Feb '25Jun '25Oct '25Feb '26-80%0%80%160%240%

Annual Revenue by Segment ($M)

20222023202420252026*$0M$0M$1M$1M$1M
  • Dispensary
  • Cultivation
  • Manufacturer

Year-over-Year Comparison

Same-month comparison across 2024, 2025, and 2026 — identify seasonal patterns and growth trajectory

Monthly Revenue Overlay by Year ($M)

JanFebMarAprMayJunJulAugSepOctNovDec$0.0M$0.0M$0.1M$0.1M$0.1M
  • 2024
  • 2025
  • 2026

Quarterly Revenue: 2024 vs 2025 ($M)

Q1Q2Q3Q4$0.0M$0.1M$0.1M$0.2M$0.3M
  • 2024
  • 2025
Q1
+23%
Q2
+88%
Q3
+93%
Q4
+110%

Seasonality & Market Structure

Average monthly revenue patterns and how market segments have shifted over time

Average Revenue by Month ($M, all years)

Gold = peak · Red = trough · Teal = all other months

JanFebMarAprMayJunJulAugSepOctNovDec$0M$0.025M$0.05M$0.075M$0.1M

Market Segment Share Over Time (%)

Manufacturer share grew from ~12% to ~27% as supply chain matured

Jan '22May '22Sep '22Jan '23May '23Sep '23Jan '24May '24Sep '24Jan '25May '25Sep '25Jan '260%30%60%110.1%
  • Dispensary
  • Cultivation
  • Manufacturer

Patient Growth & Engagement

Registered patients, utilization rates, revenue per visit, and self-certification program trajectory

Registered vs. Active Patients Over Time

Jan '22Apr '22Jul '22Oct '22Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '26030,00060,00090,000120,000
  • Registered Patients
  • Patients Served

Monthly Utilization Rate (%)

% of registered patients who shopped that month

Jan '22Jun '22Nov '22Jan '24Jun '24Nov '24Apr '25Sep '25Feb '260%20%40%60%80%

Latest: 31% in Feb 2026

Revenue Per Patient Visit ($)

Avg dispensary revenue per patient served

Jan '22Jun '22Nov '22Jan '24Jun '24Nov '24Apr '25Sep '25Feb '26$0$2$4$6$8

Latest: $2 in Feb 2026

Self-Cert: New vs. Cumulative

Monthly new registrations (bars) + running total (line)

Jan '24Jun '24Nov '24Apr '25Sep '2503,5007,00010,50014,000045,00090,000135,000180,000

Product Category Deep Dive

Sales by product type, category trends over time, and year-over-year growth by category

Top 6 Product Categories — Monthly Sales Trend ($M)

Jan '24May '24Sep '24Jan '25May '25Sep '25Jan '26$0.00M$0.85M$1.70M$2.55M$3.40M
  • Flower/Bud
  • Vape Cartridge
  • Infused Edible
  • Raw Pre-Roll
  • Infused Concentrate
  • Shake/Trim

Category Revenue: 2024 vs 2025 ($M) — Gold = >100% YoY growth

$0.0M$9.0M$18.0M$27.0M$36.0MFlower/BudVape CartridgeInfused EdibleRaw Pre-RollInfused ConcentrateShake/TrimPill/Capsule/Suppo…Tincture
  • 2024
  • 2025
Flower/Bud
$32.24M
+63% YoY
Vape Cartridge
$10.45M
+242% YoY
Infused Edible
$6.40M
+195% YoY
Raw Pre-Roll
$5.08M
+213% YoY
Infused Concentrate
$1.19M
-47% YoY
Shake/Trim
$1.16M
-34% YoY
Pill/Capsule/Suppo…
$1.09M
+42% YoY
Tincture
$0.89M
+75% YoY

Patient Geographic Origins

Where reciprocity patients come from — top states by cumulative visits

Top States — Monthly Patient Visits

Jan '24May '24Sep '24Jan '25May '25Sep '25Jan '2601,5003,0004,5006,000
  • VA
  • MD
  • NC
  • FL
  • TX

All-Time State Totals (Cumulative Visits)

1VA
61,668
2MD
33,913
3NC
11,058
4FL
6,310
5TX
5,127

Maryland and Virginia together account for the majority of all out-of-state reciprocity patients, reflecting DC's position within the DMV metro area.

Complete Monthly Data Table

All official ABCA figures — full reference for all months with computed metrics

MonthTotal RevenueDispensaryCultivationManufacturerRegistered PtsServed PtsUtilizationRev/PatientNew Self-CertsCum. Self-Certs
Jan 2022$50K$38K$12K$0K9,8006,20063%$6
Feb 2022$48K$36K$12K$0K10,1006,40063%$6
Mar 2022$54K$41K$13K$0K10,4006,70064%$6
Apr 2022$56K$42K$14K$0K10,7006,90064%$6
May 2022$57K$43K$14K$0K11,0007,10065%$6
Jun 2022$59K$45K$15K$0K11,3007,30065%$6
Jul 2022$60K$45K$15K$0K11,6007,50065%$6
Aug 2022$61K$46K$15K$0K11,9007,70065%$6
Sep 2022$60K$46K$15K$0K12,2007,90065%$6
Oct 2022$63K$47K$16K$0K12,5008,10065%$6
Nov 2022$64K$48K$16K$0K12,8008,30065%$6
Dec 2022$68K$51K$17K$0K13,1008,60066%$6
Jan 2023$42K$32K$13K$0K
Feb 2023$42K$32K$15K$0K
Mar 2023$136K$36K$51K$0K
Apr 2023$49K$36K$17K$0K
May 2023$44K$33K$15K$0K
Jun 2023$141K$33K$51K$0K
Jul 2023$46K$30K$16K$0K
Aug 2023$48K$30K$18K$0K
Sep 2023$139K$30K$50K$0K
Oct 2023$79K$29K$19K$0K22,00014,00064%$2
Nov 2023$85K$29K$20K$0K30,00018,00060%$2
Dec 2023$172K$31K$35K$55K40,00028,00070%$1
Jan 2024$40K$26K$9K$5K25,1919,95140%$31,54225,142
Feb 2024$41K$25K$11K$5K25,2289,41737%$31,41526,557
Mar 2024$42K$27K$10K$5K25,46310,10040%$31,73028,287
Apr 2024$50K$29K$11K$10K26,07811,23843%$32,18930,476
May 2024$46K$27K$11K$7K26,83811,37242%$22,44632,922
Jun 2024$44K$28K$9K$6K28,29212,11943%$22,79735,719
Jul 2024$45K$27K$10K$8K28,41212,06142%$22,75938,478
Aug 2024$45K$28K$8K$9K26,20412,69948%$22,84941,327
Sep 2024$39K$26K$6K$7K26,89211,74144%$22,66643,993
Oct 2024$45K$27K$10K$8K27,68512,73646%$23,21347,206
Nov 2024$40K$29K$5K$6K28,74113,45147%$23,48250,688
Dec 2024$41K$28K$5K$8K29,67713,51846%$23,58054,268
Jan 2025$46K$28K$8K$10K30,90413,50344%$23,46957,737
Feb 2025$46K$28K$9K$9K33,54014,98045%$23,87561,612
Mar 2025$59K$37K$8K$14K37,68820,12753%$27,01268,624
Apr 2025$90K$55K$6K$29K45,83533,38473%$213,90482,528
May 2025$90K$58K$7K$25K53,39434,53565%$213,40395,931
Jun 2025$84K$54K$8K$23K59,34627,75647%$212,457108,388
Jul 2025$88K$54K$8K$26K65,81232,28049%$211,799120,187
Aug 2025$82K$54K$6K$22K73,40732,44044%$210,369130,556
Sep 2025$78K$52K$5K$21K78,76831,28940%$29,657140,213
Oct 2025$90K$58K$7K$25K84,56034,69541%$210,975151,188
Nov 2025$85K$57K$7K$20K90,81133,74637%$29,568160,756
Dec 2025$91K$58K$8K$24K94,06733,90136%$29,872170,628
Jan 2026$87K$57K$8K$22K99,71032,87433%$2
Feb 2026$85K$55K$8K$23K104,43332,74031%$2
Mar 2026$93K$63K$6K$25K
★ = All-time record month  ·  Source: ABCA Medical Cannabis Program Metrics Reports  ·  All figures in USD

Data Source: All figures sourced directly from official ABCA (Alcoholic Beverage and Cannabis Administration) Medical Cannabis Program Metrics reports. Data covers 51 months from Jan 2022 through Mar 2026. Insights are automatically computed from the raw data and do not constitute financial or investment advice. For official reports, visit abca.dc.gov.